| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,839 |
4,783 |
$1.77M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,746 |
4,530 |
$247K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,703 |
2,638 |
$167K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,211 |
2,168 |
$160K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,091 |
1,080 |
$102K |
| G9920 |
Screening performed and negative |
1,946 |
1,910 |
$68K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
712 |
700 |
$66K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
553 |
553 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,045 |
1,016 |
$37K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
291 |
287 |
$32K |
| 92551 |
|
2,099 |
2,065 |
$28K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
223 |
216 |
$21K |
| 99383 |
|
112 |
111 |
$10K |
| 83655 |
|
1,105 |
1,090 |
$10K |
| 99173 |
|
2,034 |
2,003 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
578 |
576 |
$9K |
| 99382 |
|
58 |
57 |
$6K |
| 85018 |
|
2,720 |
2,679 |
$5K |
| 90633 |
|
313 |
308 |
$3K |
| 90670 |
|
207 |
197 |
$3K |
| 96127 |
|
405 |
402 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
81 |
81 |
$2K |
| 90651 |
|
96 |
93 |
$2K |
| 90671 |
|
131 |
130 |
$1K |
| 90697 |
|
105 |
98 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
32 |
32 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
184 |
183 |
$1K |
| 90656 |
|
57 |
56 |
$647.32 |
| 90674 |
|
57 |
55 |
$615.60 |
| 90710 |
|
52 |
52 |
$567.00 |
| 90619 |
|
29 |
27 |
$507.23 |
| 87400 |
|
84 |
42 |
$486.36 |
| 90696 |
|
43 |
43 |
$464.40 |
| 90680 |
|
39 |
38 |
$421.20 |
| 90715 |
|
27 |
25 |
$291.60 |
| 90700 |
|
27 |
26 |
$291.60 |
| 90707 |
|
12 |
12 |
$135.00 |
| 86710 |
|
13 |
13 |
$130.14 |
| 90716 |
|
12 |
12 |
$129.60 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15 |
15 |
$101.25 |
| 81003 |
|
52 |
52 |
$81.64 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
75 |
74 |
$3.75 |
| 3725F |
|
311 |
309 |
$0.00 |